Quarterly was a big improvement. I agree good value at these levels.Is likely looking for some cash though, so t/o still on the cards as they cannot do a placement here.I've traded out, but am looking to re-enter at these levels.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025